This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Shilpa Medicare Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Veera Reddy Yenireddy: Innovator in Pharmaceutical Chemistry
Introduction
Veera Reddy Yenireddy is a notable inventor based in Raichur, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds. His work has led to advancements in the preparation of specific chemical entities that have therapeutic applications.
Latest Patents
Veera Reddy Yenireddy holds a patent for "Substantially pure vemurafenib and its salts." This invention relates to a process for the preparation of substantially pure propane-1-sulfonic acid-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, commonly known as Vemurafenib. The patent also covers the preparation of Vemurafenib triflate, a salt form of the compound, which is crucial for its pharmaceutical applications. He has 1 patent to his name.
Career Highlights
Veera Reddy Yenireddy is associated with Shilpa Medicare Limited, a company known for its focus on developing and manufacturing high-quality pharmaceutical products. His role in the company has allowed him to contribute to various innovative projects that aim to improve patient outcomes through advanced medication.
Collaborations
Veera has collaborated with several professionals in his field, including Nagnnath Kokare and Purohit Prashant. These collaborations have fostered a productive environment for research and development, leading to significant advancements in pharmaceutical chemistry.
Conclusion
Veera Reddy Yenireddy's contributions to the field of pharmaceutical chemistry exemplify the impact of innovation in healthcare. His work on Vemurafenib and its salts showcases the importance of research in developing effective treatments. His career continues to inspire future inventors in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile